Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

From Verus to Meritage: A Biotech Prototype for Tough Economic Times

This article was originally published in Start Up

Executive Summary

Prolific entrepreneur Cam Garner has a new model for start-ups. Gone are the days of raising huge A rounds to build commercial infrastructure and license in families of products. His two new firms, Meritage and Evoke, are narrowly focused on single assets, in each case a reformulation of an approved drug repositioned in an underserved specialty indication.
Advertisement

Related Content

Meritage Weighs Its Options As It Looks Toward Phase III
Meritage Weighs Its Options As It Looks Toward Phase III
Safety Problems Help AstraZeneca Win Suit Brought By Former Partner Verus
Safety Problems Help AstraZeneca Win Suit Brought By Former Partner Verus
The A-List: 2009's Trend-Shaping Series A Financings
Tranzyme Takes On Diabetic Gastroparesis With Novel Ghrelin Agonist
VC Term Sheets: Liquidation Preference and Participating Preferred
Verus' Childs' Play Brings in $98 Million A Round
VC Term Sheets: Liquidation Preference and Participating Preferred
Verus' Childs' Play Brings in $98 Million A Round

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC091756

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel